SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009520
Filing Date
2020-08-06
Accepted
2020-08-06 08:31:32
Documents
84
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20200630x10q.htm   iXBRL 10-Q 2384020
2 EX-10.1 anip-20200630xex10d1.htm EX-10.1 149121
3 EX-31.1 anip-20200630xex31d1.htm EX-31.1 11349
4 EX-31.2 anip-20200630xex31d2.htm EX-31.2 10733
5 EX-32.1 anip-20200630xex32d1.htm EX-32.1 8554
  Complete submission text file 0001558370-20-009520.txt   9230124

Data Files

Seq Description Document Type Size
6 EX-101.SCH anip-20200630.xsd EX-101.SCH 55022
7 EX-101.CAL anip-20200630_cal.xml EX-101.CAL 66417
8 EX-101.DEF anip-20200630_def.xml EX-101.DEF 214896
9 EX-101.LAB anip-20200630_lab.xml EX-101.LAB 406442
10 EX-101.PRE anip-20200630_pre.xml EX-101.PRE 397077
11 EXTRACTED XBRL INSTANCE DOCUMENT anip-20200630x10q_htm.xml XML 1886432
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 201079991
SIC: 2834 Pharmaceutical Preparations